However, the mechanisms underlying SOX2/OCT4 overexpression in CSCs are not fully understood, and the role of SOX2/OCT4 overexpressing cells in tumor initiation, progression and response to cancer therapies has not been well documented. Here, SOX2 is linked to neoplasm.